Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: Bouf who wrote (8123)	6/9/1999 1:31:00 PM
From: Bucky Katt	Read Replies (1) \| Respond to of 57584

BLTI has FDA approval news out today. I don't know if it will move it, but it may be one to watch. The FDA has approved for use with children a dental laser developed, manufactured and sold by Biolase Technology, Inc. (NASDAQ: BLTI - news) that will make pain-free, faster dentistry possible for the estimated 80 million U.S. children who require dental care. Biolase Technology's Millennium Hydrokinetic YSGG(TM) dental laser, which the FDA recently cleared for adults, employs a proprietary technology that combines laser energy and water to painlessly cut hard tissue such as enamel and dentin, and removes cavities and soft tissue, without anesthesia or needles in most cases. Because there is reduced trauma, and no need for general anesthesia and conscious sedation, the dentist has the option of treating more teeth in one visit, making treatment more efficient for both the patient and the dentist.